header
Image from OpenLibrary

Induction therapy in renal transplantation / Ahmed Fathi Mohammed ; supervised Magdy Soliman , Gamal Saady , Mona Roshdy

By: Contributor(s): Language: Eng Publication details: Cairo : Ahmed Fathi Mohammed , 2006Description: 183P : ill ; 25cmOther title:
  • العلاج المثبط للمناعة فى زرع الكلى [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Internal Medicine Summary: The past decade has witnessed unprecedented advances in renal transplantation propelled by novel and effective immunosuppression drugsThe introduction of mycophenolate mofetil (MMF) , tacrolimus , cyclosporine microemulsion , sirolimus , a new generation of monoclonal antibodies (the anti - interleukin - 2 receptor blockers , daclizumab and basiliximab) , and the depleting polyclonal biological Thymoglobulin has provided transplant physicians with a wide choice in selecting effective immunosuppression regimens
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.18.M.Sc.2006.Ah.I. (Browse shelf(Opens below)) Not for loan 01010110046061000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.18.M.Sc.2006.Ah.I. (Browse shelf(Opens below)) Not for loan 01020110046061000

Thesis (M.Sc.) - Cairo University - Faculty Of Medicine - Department Of Internal Medicine

The past decade has witnessed unprecedented advances in renal transplantation propelled by novel and effective immunosuppression drugsThe introduction of mycophenolate mofetil (MMF) , tacrolimus , cyclosporine microemulsion , sirolimus , a new generation of monoclonal antibodies (the anti - interleukin - 2 receptor blockers , daclizumab and basiliximab) , and the depleting polyclonal biological Thymoglobulin has provided transplant physicians with a wide choice in selecting effective immunosuppression regimens

Issued also as CD

There are no comments on this title.

to post a comment.